When it Rains it Pours: The State of New Jersey Requests Amgen Documents for Off-Label Marketing of Enbrel
.gif)
Still reeling from lawsuits filed last week by ex-sales reps’ alleging improper marking of Enbrel to treat patients with psoriasis, Amgen was subpoenaed on Monday by New Jersey's attorney general regarding allegations that the company promoted Enbrel for unapproved uses.
In the subpoena served Monday, Attorney General Anne Milgram is seeking "a comprehensive array of documents and information" concerning the marketing and sale of Enbrel from July 2002 to the present.
The subpoena calls for Amgen to deliver the required materials by Feb. 4.
Although doctors are free to prescribe medicines as they see fit, drug companies are only allowed to promote their products for uses that have been approved by the U.S. Food and Drug Administration and appear on product labels.
Until next time…
Good Luck and Good Job Hunting!!!!!!!!
